Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversibility with Tiotropium (SPIRIVA) in COPD: lung function, dyspnea and CT
2008-001495-69Phase 2Active
- Sponsor
- CHU de Lille
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by CHU de Lille. Primary endpoint: Bronchial resistance and resting lung hyperinflation. Started May 2008; status: active.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-001495-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001495-69.